Truist Securities lowered Elevance Health (NYSE:ELV) price target from $610 to $580

By / / Elevance

Truist Securities analyst Tobey Sommer maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $610 to $580.

Scroll to Top